Severe Cutaneous Reaction and Fever Due to Adalimumab

2010 ◽  
Vol 105 (6) ◽  
pp. 490-491 ◽  
Author(s):  
M. Angeles Gonzalo-Garijo ◽  
Isabel Rodríguez-Nevado ◽  
Remedios Pérez-Calderón ◽  
Silvia Sánchez-Vega ◽  
Inmaculada Pérez-Rangel
Keyword(s):  
Cutaneous Reaction ◽  
Severe Cutaneous Reaction

Severe cutaneous reaction to CS gas

2001 ◽  
Vol 26 (3) ◽  
pp. 248-250 ◽  
Author(s):  
S. Varma ◽  
P. J. A. Holt
Keyword(s):  
Cutaneous Reaction ◽  
Severe Cutaneous Reaction

Severe cutaneous reaction due to terazosin

The Lancet ◽  
1998 ◽  
Vol 352 (9123) ◽  
pp. 202-203 ◽  
Author(s):  
Natalia Hernández-Cano ◽  
Pedro Herranz ◽  
Teresa E Lázaro ◽  
Matías Mayor ◽  
Mariano Casado
Keyword(s):  
Cutaneous Reaction ◽  
Severe Cutaneous Reaction

Severe cutaneous reaction following measles immunization

2009 ◽  
Vol 48 (8) ◽  
pp. 873-874 ◽  
Author(s):  
Arun C. Inamadar ◽  
Shailaja S. Patil ◽  
Aparna Palit
Keyword(s):  
Cutaneous Reaction ◽  
Severe Cutaneous Reaction

P1208 PREDICTION OF SEVERE CUTANEOUS REACTION DURING TRIPLE THERAPY IN HCV: VALIDATION OF A GWAS CANDIDATE GENETIC MARKER

2014 ◽  
Vol 60 (1) ◽  
pp. S490-S491
Author(s):  
E. Palescandolo ◽  
L. Vijgen ◽  
W. Talloen ◽  
M. Colombo ◽  
A. Mangia ◽  
...  
Keyword(s):  
Triple Therapy ◽  
Genetic Marker ◽  
Cutaneous Reaction ◽  
Severe Cutaneous Reaction

scholarly journals Intravenous Voriconazole after Toxic Oral Administration

2009 ◽  
Vol 54 (6) ◽  
pp. 2741-2742 ◽  
Author(s):  
J. W. C. Alffenaar ◽  
S. van Assen ◽  
J. G. R. de Monchy ◽  
D. R. A. Uges ◽  
J. G. W. Kosterink ◽  
...  
Keyword(s):  
Oral Administration ◽  
Invasive Aspergillosis ◽  
Liver Enzyme ◽  
Male Patient ◽  
Intravenous Administration ◽  
Portal Blood ◽  
Cutaneous Reaction ◽  
High Concentrations ◽  
Severe Cutaneous Reaction

ABSTRACT In a male patient with rhinocerebral invasive aspergillosis, prolonged high-dosage oral administration of voriconazole led to hepatotoxicity combined with a severe cutaneous reaction while intravenous administration in the same patient did not. High concentrations in the portal blood precipitate liver enzyme abnormalities, and therefore, oral administration of voriconazole may have a hepatotoxicity profile different from that of intravenous (i.v.) administration. Intravenously administered voriconazole might still be an option after oral-voriconazole-induced toxicity has resolved.

Sign in / Sign up

Export Citation Format

Share Document